Rapid ICH 3.0 and Rapid Hyperdensity are designed to support clinicians managing intracranial hemorrhage, including hemorrhagic stroke and head trauma. Two studies presented at the International Stroke Conference 2023 evaluated these technologies.
The studies were conducted by Dr. Anirudh Sreekrishnan of Stanford Medicine and co-authors and were presented by Dr. Sreekrishnan at ISC.
Key takeaways:
The latest version of Rapid ICH evaluated non-contrast CT scans for intracranial hemorrhage. In the peer-reviewed Rapid ICH 3.0 study, the software showed 97.84% sensitivity, 99.52% specificity, 99.56% positive predictive value and 97.65% negative predictive value.
The peer-reviewed analysis included 881 NCCT examinations. The software processed exams in under one minute and detected multiple hemorrhage subtypes.
Dr. Sreekrishnan and co-authors also evaluated whether Rapid Hyperdensity could automatically quantify hemorrhage volume and detect changes on follow-up NCCT scans. Expert neuroradiologists and the software evaluated baseline and 24-hour follow-up scans from 127 patients.
The peer-reviewed study found a high correlation between automated and manual baseline hemorrhage-volume measurements and between measurements of change on follow-up imaging. For detecting ICH expansion, the software had 94.12% sensitivity and 97.27% specificity.
Rapid ICH and Rapid Hyperdensity automatically process non-contrast CT images and provide findings that can give clinicians additional context for triage and transfer decisions. Rapid ICH 3.0 assesses scans for intraparenchymal, intraventricular, subdural and subarachnoid hemorrhage.
Learn more about the Rapid ICH 3.0 and Rapid Hyperdensity modules.